Is extracorporeal hypothermic machine perfusion of the liver better than the 'good old icebox'?

Current Opinion in Organ Transplantation

Volumn 17, Issue 2, 2012, Pages 137-142

  Bae, Coney ^a   Henry, Scot D ^a   Guarrera, James V ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

extended criteria donor; graft viability assessment; hypothermic machine perfusion; ischemia reperfusion injury; liver transplant

Indexed keywords

CYTOKINE; METHYLPREDNISOLONE; NITRIC OXIDE;

ALLOGRAFT; BILIARY TRACT DISEASE; BIOMECHANICS; CELL RESPIRATION; CRYOPRESERVATION; DISEASE SEVERITY; HUMAN; HYPOTHERMIC MACHINE PERFUSION; ISCHEMIA; LIVER GRAFT REJECTION; LIVER PRESERVATION; LIVER SINUSOID; LIVER TRANSPLANTATION; MOLECULAR MECHANICS; NONHUMAN; ORGAN CIRCULATION; REPERFUSION INJURY; REVIEW;

CRYOPRESERVATION; GRAFT SURVIVAL; HUMANS; LIVER; LIVER TRANSPLANTATION; ORGAN PRESERVATION; PERFUSION; REPERFUSION INJURY; TISSUE DONORS; TRANSPLANTS;

EID: 84858792022     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328351083d     Document Type: Review

References (46)

1. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10:372-381.
2. Daemen JW, Oomen AP, Kelders WP, Kootstra G. The potential pool of nonheart-beating kidney donors. Clin Transplant 1997; 11:149-154. (Pubitemid 27168538)
3. Berendsen TA, Izamis ML, Xu H, et al. Hepatocyte viability and adenosine triphosphate content decrease linearly over time during conventional cold storage of rat liver grafts. Transplant Proc 2011; 43:1484-1488.
4. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45:673-676.
5. Minor T, Manekeller S, Sioutis M, Dombrowski F. Endoplasmic and vascular surface activation during organ preservation: refining upon the benefits of machine perfusion. Am J Transplant 2006; 6:1355-1366. (Pubitemid 44030318)
6. Stegemann J, Minor T. Energy charge restoration, mitochondrial protection and reversal of preservation induced liver injury by hypothermic oxygenation prior to reperfusion. Cryobiology 2009; 58:331-336.
7. Harvey PRC. Adenine nucleotide tissue concentrations and liver allograft viability after cold preservation and warm ischemia. Transplantation 1988; 45:1016.
8. Kamiike W. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 1988; 45:138.
9. Lüer B. Role of oxygen during hypothermic machine perfusion preservation of the liver. Transpl Int 2010; 23:944.
10. Guarrera JV, Henry SD, Chen SW, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res 2011; 167:e365-e373.
11. Tulipan JE, Stone J, Samstein B, et al. Molecular expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies. Surgery 2011; 150:352-360.
12. Lee CY, Zhang JX, deSilva H, et al. Heterogeneous flow patterns during hypothermic machine perfusion preservation of livers. Transplantation 2000; 70:1797-1802.
13. Lee CY, Zhang JX, Jones JW Jr, et al. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation 2002; 74:944-951. (Pubitemid 35191241)
14. Dutkowski P, Graf R, Clavien PA. Rescue of the cold preserved rat liver by hypothermic oxygenated machine perfusion. Am J Transplant 2006; 6:903-912. (Pubitemid 44356640)
15. Debbaut C, Monbaliu D, Casteleyn C, et al. From vascular corrosion cast to electrical analog model for the study of human liver hemodynamics and perfusion. IEEE Trans Biomed Eng 2011; 58:25-35.
16. Hart NA, der van Plaats A, Leuvenink HG, et al. Determination of an adequate perfusion pressure for continuous dual vessel hypothermic machine perfusion of the rat liver. Transpl Int 2007; 20:343-352.
17. Minor T. Endoplasmic and vascular surface activation during organ preservation: refining upon the benefits of machine perfusion. Am J Transplant 2006; 6:1355-1366. (Pubitemid 44030318)
18. Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg 2006; 13:517-524. (Pubitemid 46766707)
19. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253:817-825.
20. Pirenne J, Van Gelder F, Coosemans W, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001; 7:540-545. (Pubitemid 32547271)
21. Pacheco EG, Silva OD Jr, Sankarankutty AK, Ribeiro MA Jr. Analysis of the liver effluent as a marker of preservation injury and early graft performance. Transplant Proc 2010; 42:435-439.
22. Matsuno N, Kozaki K, Degawa H, et al. A useful predictor in machine perfusion preservation for kidney transplantation from nonheart-beating donors. Transplant Proc 2000; 32:173-174. (Pubitemid 30100798)
23. Valero R, Garcia-Valdecasas JC, Tabet J, et al. Hepatic blood flow and oxygen extraction ratio during normothermic recirculation and total body cooling as viability predictors in nonheart-beating donor pigs. Transplantation 1998; 66:170-176. (Pubitemid 28369995)
24. Guarrera JV, Goldstein MJ, Samstein B, et al. 'When good kidneys pump badly': outcomes of deceased donor renal allografts with poor pulsatile perfusion characteristics. Transpl Int 2010; 23:444-446.
25. Verran D, Kusyk T, Painter D, et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 2003; 9:500-505. (Pubitemid 36621720)
26. Spitzer AL, Lao OB, Dick AA, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16:874-884.
27. Perez-Daga JA, Santoyo J, Suarez MA, et al. Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation. Transplant Proc 2006; 38:2468-2470. (Pubitemid 44767862)
28. Berthiaume F, Barbe L, Mokuno Y, et al. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res 2009; 152:54-60.
29. Bessems M, Doorschodt BM, Kolkert JL, et al. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl 2007; 13:497-504. (Pubitemid 46605850)
30. Chavin KD, Fiorini RN, Shafizadeh S, et al. Fatty acid synthase blockade protects steatotic livers from warm ischemia reperfusion injury and transplantation. Am J Transplant 2004; 4:1440-1447. (Pubitemid 39159058)
31. Nagrath D, Xu H, Tanimura Y, et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab Eng 2009; 11:274-283.
32. Izamis ML. Ex vivo perfusion optimization of donor liver grafts for transplantation and cell isolation [thesis]. Boston, Massachusetts: Massachusetts Institute of Technology; 2010.
33. Minor T, Luer B, Efferz P. Dopamine improves hypothermic machine preservation of the liver. Cryobiology 2011; 63:84-89.
34. Brinkkoetter PT, Beck GC, Gottmann U, et al. Hypothermia-induced loss of endothelial barrier function is restored after dopamine pretreatment: role of p42/p44 activation. Transplantation 2006; 82:534-542. (Pubitemid 44290260)
35. Brinkkoetter PT, Song H, Losel R, et al. Hypothermic injury: the mitochondrial calcium, ATP and ROS love-hate triangle out of balance. Cell Physiol Biochem 2008; 22:195-204.
36. Monbaliu D, Vekemans K, Hoekstra H, et al. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from nonheart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg 2009; 250:808-817.
37. Saidi RF, Chang J, Verb S, et al. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. Am J Surg 2007; 193:345-347; discussion 7-8.
38. Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248:1042-1050.
39. Lang JD Jr, Teng X, Chumley P, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117:2583-2591. (Pubitemid 47494359)
40. Beck GC, Oberacker R, Kapper S, et al. Modulation of chemokine production in lung microvascular endothelial cells by dopamine is mediated via an oxidative mechanism. Am J Respir Cell Mol Biol 2001; 25:636-643. (Pubitemid 33087115)
41. Roy N, Friehs I, Cowan DB, et al. Dopamine induces postischemic cardiomyocyte apoptosis in vivo: an effect ameliorated by propofol. Ann Thorac Surg 2006; 82:2192-2199.
42. de Rougemont O, Dutkowski P, Clavien PA. Biological modulation of liver ischemia-reperfusion injury. Curr Opin Organ Transplant 2010; 15:183-189.
43. Baskin-Bey ES. Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant 2007; 7:218-225. (Pubitemid 44952876)
44. Stegemann J, Himer A, Rauen U, Minor T. Use of a new modified HTK solution for machine preservation of marginal liver grafts. J Surg Res 2010; 160:155.
45. Rauen U. New insights into the cellular and molecular mechanisms of cold storage injury. J Investig Med 2004; 52:299.
46. Rauen U. Cold-induced apoptosis of hepatocytes: mitochondrial permeability transition triggered by nonmitochondrial chelatable iron. Free Radic Biol Med 2003; 35:1664.